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Abstract
Background: The independent influence of blood culture testing and bloodstream infection (BSI) on hospital
mortality is unclear.
Methods: We included all adults treated in non-psychiatric services at our hospital between 2004 and 2011. We
identified all blood cultures and their results to determine the independent association of blood culture testing and
BSI on death in hospital using proportional hazards modeling that adjusted for important covariates.
Results: Of 297 070 hospitalizations, 48 423 had negative blood cultures and 5274 had BSI. 12 529 (4.2%) died in
hospital. Compared to those without blood cultures, culture-negative patients and those with BSI were sicker.
Culture-negative patients had a significantly increased risk of death in hospital (adjusted hazard ratio [HR] ranging
between 3.1 and 4.4 depending on admission urgency, extent of comorbidities, and whether the blood culture was
taken in the intensive care unit). Patients with BSI had a significantly increased risk of death (adj-HR ranging between
3.8 and 24.3] that was significantly higher when BSI was: diagnosed within the first hospital day; polymicrobial; in
patients who were exposed to immunosuppressants or were neutropenic; or due to Clostridial and Candidal
organisms. Death risk in culture negative and bloodstream infection patients decreased significantly with time.
Conclusions: Risk of death in hospital is independently increased both in patients with negative blood
cultures and further in those with bloodstream infection. Death risk associated with bloodstream infections
varied by the patient’s immune status and the causative microorganism.
Keywords: Blood stream infections, Hospital mortality, Outcomes, Proportional hazards modeling
Background
Blood cultures are commonly ordered in clinical practice
with bloodstream infections found in almost all medical
specialties. Blood cultures are typically ordered when
physicians suspect the possibility of a bloodstream infec-
tion. Both the test and its result signal important events
in a patient’s care: blood cultures are often performed
when patients are ill or when their conditions signifi-
cantly worsen; bloodstream infections frequently change
treatment, often invoke a search for both causes and
manifestations of the infection, and may indicate a sig-
nificant turning point in a patient’s health.
Despite the prevalence of blood cultures and the im-
portance of bloodstream infections, their impact on hos-
pitalized patient outcomes is unclear. Previous studies of
blood cultures and hospital mortality have focused on
specific patient populations [1-6], specific microorgan-
isms [7-10], or both [11]. Other studies focused their
mortality analysis on patients with documented blood-
stream infections to the exclusion of those with negative
blood cultures [12-16]. A few studies have compared
hospital mortality in patients with or without a blood-
stream infection but studied a restricted population in-
cluding those admitted with acute on chronic hepatic
failure [1] and critically ill patients with catheter-related
blood stream infections [2]. Finally, no previous studies
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have determined the influence of simply having a blood
culture measured during the hospital – independent of
its results – on hospital mortality in a broad patient
population.
Knowing the effect of bloodstream infections on pa-
tient outcomes is needed to determine their importance
in patient care. In this study, we measured the independ-
ent influence of blood cultures and bloodstream infec-
tions on the risk of death in hospital.
Methods
Study setting
This study took place at The Ottawa Hospital (TOH), a
tertiary-care teaching facility with three in-patient sites
that averaged 20 000 admissions annually during the
study period. TOH functions within a publicly funded
health care system, is the sole trauma centre for the re-
gion, and provides most of the region’s oncological, thor-
acic surgery, and neurosurgical care.
Patients
We included all non-psychiatric hospitalizations of
people over 15 years of age between 1 April 2004 and 31
March 2011 including same-day surgeries. This study
period was chosen to maximize the study sample size
given the data available at the time we conducted the
study. Psychiatry admissions were not included since
physically ill patients potentially requiring blood cultures
are rarely admitted to – or are readily transferred from –
the psychiatry service. We excluded patients who were
transferred from or to other hospitals since we could not
get admission data or mortality status, respectively. The
unit of analysis in this study was the hospitalization.
Blood culture utilization and results
We linked to the laboratory database to determine if and
when each hospitalized patient had a blood culture mea-
sured. Cultures collected in the emergency department
prior to admission were also captured and attributed to the
hospitalization. Each day of each person’s hospitalization
was divided into six-hour sections starting at the time the
patient was admitted to hospital. For each of these quarter-
day segments, we determined whether or not the person
had at least one blood culture measured.
Results of all blood cultures were then retrieved. Likely
contaminants were identified using criteria modified
from Richter [17] in which coagulase-negative staphylo-
cocci, aerobic and anaerobic diphtheroids, Micrococcus
spp., Bacillus spp., and viridans group streptococci were
classified as contaminants in the absence of another blood
culture within 48 hours growing the same organism. Mi-
croorganisms identified on the final report were clustered
by their genus into microorganism groups that were based
on the chapter (in a commonly used textbook of infectious
diseases [18]) which contained most information about
the organism. Blood cultures growing more than one or-
ganism were classified as polymicrobial.
Outcome and covariates
The primary outcome of the study was all-cause death
in hospital. The primary covariate was the risk of death
in hospital calculated using an extension of a model by
Escobar et al. [19]. The “Escobar model” estimates the
probability of death in hospital based on covariates avail-
able at the time of admission including: patient age and
sex; admission urgency (i.e. elective or emergent) and
service (i.e. medical or surgical); admission diagnosis;
severity of acute illness as measured by the Laboratory-
based Acute Physiology Score (LAPS); chronic comor-
bidities as measured by the Elixhauser score [20]; and
admission diagnosis [19]. The Escobar model was highly
discriminative, well calibrated, and was externally vali-
dated in our center with a c-statistic of 0.901 [21].
In the present study, we used a validated extension of
the Escobar model to calculate each person’s daily risk
of death in hospital [22]. The “Daily Escobar” model in-
cluded all of the covariates in the Escobar model but
expressed LAPS as a time-dependent covariate (i.e. its
value was allowed to change with time) in which we
used the most extreme value of each laboratory test in
each 6-hour segment to calculate the LAPS. It also in-
cluded three additional time-dependent covariates: ad-
mission to intensive care unit [determined by linking to
the hospital’s patient location table]; performance of
significant operative procedures [23] [determined by link-
ing to the hospital’s procedure table]; and awaiting long-
term care status. The “Daily Escobar” model also had
excellent discrimination (concordance probability of 0.895,
95% CI 0.889-0.902) and calibration.
Other time-dependent covariates were also examined.
We linked to the hospital’s laboratory dataset to determine
each patient’s neutrophil count throughout the admission;
counts <500 × 109 neutrophils/mL were classified as neu-
tropenic. We also linked to the pharmacy dataset to deter-
mine if patients received immunosuppressive medications
including enteral or parenteral steroids, methotrexate, aza-
thioprine, mycophenolate mofetil, cyclosporine, or anti-
thymocyte globulin.
Analysis
For baseline descriptive purposes, we separated patients
into three exclusive groups: no blood cultures done dur-
ing hospitalization; at least one blood culture but no
bloodstream infection; or one or more bloodstream infec-
tions. The prevalence - or median value - of each covariate
within each group was described. Blood culture utilization
was expressed as an incidence density reported as the
number of tests per 100 patient-days.
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We described how blood culture utilization and blood-
stream infections changed hospital mortality by calculat-
ing the daily expected number of deaths in each patient
group. For all patients in each group, we calculated the
estimated risk of death using the ‘Daily Escobar’ model
and then summed these daily risks to determine the ex-
pected number of deaths in each group on each day. In
this analysis, patients with a blood culture had their ref-
erence time (i.e. time 0) set at the date of their first
blood culture. Patients with no blood cultures had their
reference time set at the middle of their admission.
We then determined the association of blood culture
results with time to death in hospital using a survival
model. Observation started at hospital admission and
was censored at discharge with observation time broken
into six hour segments. Blood culture procurement and
bloodstream infection status was expressed as time-
dependent binomial covariates. We added to the model
a term expressing the number of quarters since the
blood culture had been done to quantify changes over
time between the association of blood culture measure-
ment and death in hospital. The best fitting polynomial
transformation that captured this change was determined
using a modification of a SAS macro from Sauerbrei [24].
We included terms capturing polymicrobial status and
timing of bloodstream infection (categorized as admis-
sion [positive blood culture procured within first day
of admission] vs. hospital [blood culture procured more
than 24 hours after admission]). We also determined if
significant interactions (p < 0.001) existed between each
covariate and blood culture measurement or bloodstream
infections.
The fully adjusted model determining the association
of blood cultures and bloodstream infections with death
in hospital controlled for each patient’s daily expected
risk of death in hospital. This was quantified using the
“Daily Escobar” model described above to calculate the
Xβ from the model for each patient on each day. This
daily death risk was expressed as a time-dependent covari-
ate but was kept constant after patients were diagnosed
with a bloodstream infection. This was done because the
inclusion of the daily death risk in the model – including
that after bloodstream infection was treated – would mute
the influence of bloodstream infection on outcomes. This
is because the treatment of bloodstream infection should
decrease the daily death risk score (see Figure 1) and
lower daily death risk scores are strongly associated with
a decreased risk of death. Therefore, including in the
model post-treatment daily death risk scores of blood-
stream infection patients would, because of confounding,
bias the association between bloodstream infection and
hospital death towards the null. Fisher highlighted this
potential problem with survival models using time-
dependent covariates [25].
Other time-dependent covariates offered to the model
included those capturing each patient’s neutropenic status
and exposure to immunosuppressant medications. To de-
termine if death risk varied by microorganism, we subclas-
sified bloodstream infection patients by the microorganism
group of the isolate(s). Also, we repeated the model using
only one admission per patient (i.e. a patient-level analysis
rather than an admission level analysis) to determine if our
conclusions were sensitive to this modification. Finally, we
determined the possible influence of censoring patients at
hospital discharge by conducting a competing risks model
using the methods described by Wolkewitz et al. {13665}.
This was accomplished by assessing the size of parameter
estimates in a replicate of our final model that had time to
discharge from hospital as the outcome while censoring
patients who died during their admission. The study was
approved by The Ottawa Hospital Research Ethics Board.
Results
During the study period, a total of 317 194 adult in-
patient encounters (in which patients were neither trans-
ferred from or to another facility) occurred at our hospital.
20 124 of these hospitalizations were excluded because pa-
tients were admitted and discharged from the psychiatry
service.
This left a total of 297 070 hospitalizations consisting
of 186 182 patients (Table 1). Most hospitalizations had
no blood cultures (n = 243 373, 81.9%), 16.3% of admis-
sions (N = 48 423) had all negative cultures, and 1.8%
(N = 5274) had at least one documented bloodstream in-
fection. Regardless of the result, patients having one or
more blood cultures during the hospitalization were not-
ably sicker than those without (Table 1): they were older;
they had higher Elixhauser [20] scores (indicating more
extensive chronic illnesses); they were more likely to be
admitted urgently and had a much higher predicted risk
of death in hospital; they had more extensive perturba-
tions of their laboratory tests (as indicated by their LAP
Scores); they were more likely to be treated in the inten-
sive care unit or to be exposed to immunosuppressants
at any time during the admission; and they had a longer
median length of stay.
Blood culture utilization and results
The incident rate for blood culture utilization was 3.7
culture sets per 100 patient days; bloodstream infection
incident rate was 0.25 per 100 patient days. Blood cul-
ture utilization was heavily weighted to the start of the
hospital stay; blood culture utilization rates were highest
on the first hospital day (4.5 cultures per 100 patient-days)
while utilization was subsequently significantly lower (an
average of 0.68 cultures per 100 patient-days [range 0.55-
0.79]). Bloodstream infection rates were also highest on
the first hospitalization day (0.41 bloodstream infections
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per 100 patient-days) and decreased significantly for the
rest of the hospitalization (mean rate of 0.03 bloodstream
infections per 100 patient-days, range 0.02-0.05).
Table 2 shows that the majority of people undergoing
testing had only one set of blood cultures (37 243 people,
69.4% of those having any blood culture). As well, 4721 of
the 5274 people (89.5%) with at least one positive test had
only one bloodstream infection. The ten most common
microorganisms identified in the positive blood cultures
are shown in Table 3 with Enterobacteriacae, S. Aureus,
and Streptococci being the most common. 637 of a total of
7549 bloodstream infections (8.4%) were polymicrobial
with one or more polymicrobial bloodstream infections
occurring in 502 (0.2%) hospitalizations.
Blood cultures, bloodstream infections and unadjusted
risk of hospital mortality
Patients without blood cultures were significantly less
likely to die in hospital (2.1%) than those with all nega-
tive blood cultures (13.3%) or those with at least one
bloodstream infection (20.7%) (Table 1; χ2 value 16172,
p < 0.0001).
Expected death risk varied by patient group. In pa-
tients without blood cultures, the daily expected risk of
death averaged 3.5 deaths per 1000 patient-days (range
1.8-5.0); the lowest expected death rates for this group
occurred at Time 0 (Figure 1) likely due to an increased
prevalence at this point of short stay admissions which
have the lowest expected risk of death. In contrast, the
daily expected risk of death in patients with blood cul-
tures - regardless of their result - averaged 7.5 deaths
per 1000 (range 5.6-8.7) prior to the blood culture test-
ing (Figure 1). On the day of the blood culture, however,
expected death rates increased significantly to 14.3 deaths
per 1000 patient-days in patients with negative cultures
and 24.6 deaths per 1000 patient-days in patients with
bloodstream infections. Expected death rates returned to
pre-testing values within 4 days of blood culture procure-
ment (Figure 1).
Both negative blood cultures and bloodstream infec-
tion were associated with an increased risk of death in
hospital (Figure 2A). The unadjusted death risk in pa-
tients with negative blood cultures was five times that of
people without blood cultures. The unadjusted hazard
Figure 1 Daily expected risk of death by blood culture status. The daily hazard of death was calculated for each person using a validated
predictive model that captured daily values of important, patient-level covariates [22]. Within each group (no blood culture [red], negative blood
culture [grey], positive blood culture [blue]), these were summed and standardized to 1000 population (vertical axis). The horizontal axis displays
the hospital day relative to the first blood culture; for patients with no blood culture, the hospitalization midpoint was used as the reference. The
dip in the ‘no blood culture’ group is due to increased prevalence at zero time of short stay admissions (which have the lowest expected risk
of death).
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ratio for death in patients with bloodstream infection
ranged between 6.2 and 15.8 depending on both the tim-
ing of the bloodstream infection (i.e. at admission vs. in-
hospital) and the number of organisms in the positive
culture: patients with bloodstream infection detected after
the first hospitalization day had a significantly higher
unadjusted risk of death compared to bloodstream in-
fections detected at admission; unadjusted death risk was
higher in polymicrobial bloodstream infections than in
single-microbial bloodstream infections (Figure 2A). The
increased risk of death associated with negative blood cul-
tures and bloodstream infection both decreased signifi-
cantly over time.
The unadjusted relative hazard of death in hospital with
negative blood cultures and bloodstream infection varied
significantly with several covariates. Compared to a patient
without blood culture testing, the unadjusted relative risk
of death associated with negative blood cultures was sig-
nificantly higher in patient groups having a lower risk of
death including: females (Figure 2B); younger patients
(Figure 2C); those admitted electively to hospital (Figure 2D);
patients with fewer comorbidities (Figure 2E); those with-
out immunosuppressants (Figure 2G); and patients not in
the intensive care unit (Figure 2H). The increased risk of
death associated with bloodstream infection interacted
significantly with neutropenia (Figure 2I) and immuno-
suppressant exposure (Figures 2F and 2G); compared to
patients without blood culture testing, the risk of death
with bloodstream infection was extensively and signifi-
cantly higher in patients who were neutropenic and those
exposed to immunosuppressants.
Table 1 Description of study hospitalizations
No blood culture
(N=243 373, 81.9%)
1+ Blood culture, all negative
(N=48 423, 16.3%)





Mean age (SD) 53.2 20.2 62.3 18.8 63.4 17.9 54.8 20.2
Female 145 772 59.9 23 414 48.4 2403 45.6 171 589 57.8
Elixhauser score*: <0 11206 4.6 1719 3.6 212 4.0 13 137 4.4
0 140 027 57.5 12 461 25.7 1177 22.3 153 665 51.7
>0 91 140 37.9 34 243 70.7 3885 73.7 130 268 43.8
Admission
Emergent admission 135 962 55.9 43 914 90.7 4856 92.1 184 732 62.2
Admitted to surgical service 82 721 34.0 11 116 23.0 1012 19.2 94 849 31.9
Median death risk (IQR)** 0.4% 0.1-2.1 5.1% 1.2-15.6 8.0% 2.1-22.6 0.6% 0.17-4.0
LAP score****: 0 152 338 62.6 9742 20.1 804 15.2 162 884 54.8
>0 91 035 37.4 38 681 79.9 4470 84.8 134 186 45.2
Hospitalization
Intensive care unit*** 4137 1.7 7845 16.2 1297 24.5 13 369 4.5
Surgical procedure*** 66 928 27.5 8813 18.2 964 18.2 76 649 25.8
Neutrophils < 500 × 109/L*** 730 0.3 3147 6.5 609 11.5 4456 1.5
Immunosupressant*** 6814 2.8 14 140 29.2 1763 33.3 22 579 7.6
Awaiting placement anytime 97 0.04 3680 7.6 434 8.2 4159 1.4
Median LOS (IQR) 4 2-6 9 4-19 12 6-28 4 2-8
Died in hospital 5013 2.1 6423 13.3 1093 20.7 12 529 4.2
Unless stated, numbers in right column are percentages.
SD standard deviation, IQR interquartile range.
*Measures number and severity of comorbidities [21].
**Measured using Escobar model [20] using covariate values at hospital admission.
***At any time during the hospitalization.
****Laboratory-based Acute Physiology Score; quantifies deviations of important laboratory tests from normal [20].
Table 2 Summary of blood culture utilization and results
Number of blood culture sets




0 243 373 34 854 8023 5546 291 796
(98.2%)
1 - 2389 1101 1231 4721 (1.6%)
2 - - 107 317 424 (0.1%)
3+ - - - 129 129 (0.04%)
TOTAL
243 373 37 243 9231 7223
297 070
(81.9%) (12.5%) (3.1%) (2.4%)
A maximum of 1 culture set per person per six hour period was counted.
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Table 3 Description of 8334 microoganisms identified in 7549 positive cultures
Microorganism group Isolates Frequency % Total (% of group)
Enterbacteriacae - 3024 36.3
Escherichia coli 1659 (54.9)
Klebsiella pneumoniae 534 (17.7)
Enterobacter cloacae 221 (7.3)
Other 610 (20.2)
Staphylococcus Aureus - 1065 12.8
Streptococci - 979 11.7
Streptococcus pneumoniae 321 (32.8)
Group B Streptococcus (s. agalactiae) 131 (13.4)
Viridans group Streptococcus 105 (10.7)
Other 422 (43.1)
Enterococcus (including Streptococcus bovis) - 689 8.3
Enterococcus faecalis 412 (59.8)
Enterococcus faecium 211 (30.6)
Enterococcus species 31 (4.5)
Other 35 (5.1)
Candida - 574 6.9
Candida albicans 292 (50.9)
Candida (torulopsis) glabrata 119 (20.7)
Candida parapsilosis 65 (11.3)
Other 98 (17.1)
Other gram negative and gram-variable bacilli - 538 6.5
Pseudomonas aeruginosa 381 (70.8)
Gram-negative bacilli 69 (12.8)
Achromobacter (alcaligenes) xylosoxidans 17 (3.2)
Other 71 (13.2)
Anaerobic gram-positive nonsporulating bacilli - 239 2.9
Propionibacterium acnes 114 (47.7)
Propionibacterium species 102 (42.7)
Eubacterium lentum 16 (6.7)
Other 7 (2.9)
Other anaerobes - 160 1.9
Bacteroides fragilis 99 (61.9)
Bacteroides thetaiotaomicron (fragilis gr.) 13 (8.1)
Fusobacterium nucleatum 10 (6.3)
Other 38 (23.8)
Methicillin resistant staphylococcus aureus - 153 1.8
Clostridium - 116 1.4
Clostridium perfringens 49 (42.2)
Clostridium septicum 23 (19.8)
Clostridium species 18 (15.5)
Other 26 (22.4)
Other - 797 9.6
Coagulase-negative Staphylococcus 158 (19.8)
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Figure 2 Stratified and unadjusted influence of negative blood cultures and bloodstream infection on risk of death in hospital. These
figures plot the association between day from blood culture (horizontal axis) with relative hazard of all-cause death in hospital (vertical axis) for
patients with negative blood culture (red lines) and bloodstream infection (blue lines). These estimates were generated from models in which
blood cultures were expressed as time-dependent covariates and are stratified by the characteristic in each title; therefore, the displayed hazard
of death is relative to patients in that strata who did not have blood culture testing. Plot A shows the unadjusted association. In the remaining
plots (Plot B through I), the stratifying variable for the analysis is presented atop the plot. The p-value for all of the interactions presented here
(i.e. plots B to F) is ≤ 0.0001.
Table 3 Description of 8334 microoganisms identified in 7549 positive cultures (Continued)
Stenotrophomonas maltophilia 70 (8.8)
Haemophilus influenzae 52 (6.5)
Other 517 (64.9)
Blood cultures growing two organisms in the same class were counted once. Microorganisms were classified using Mandell [19].
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Adjusted association of blood cultures and, bloodstream
infections with hospital mortality
After adjusting for important covariates, the risk of
death in hospital was significantly higher in patients with
negative blood cultures (Figure 3A, Additional file 1). This
risk ranged between 3.1 and 4.4 times that of people
without blood culture testing, varying significantly by
admission urgency (risk tended to be higher in elective ad-
missions), patient comorbidity (risk tended to be higher in
sicker patients), and ICU status (risk tended to be higher
in ICU patients). The increased risk of death associated
with negative blood cultures decreased significantly over
time.
Bloodstream infections conferred a significant, additional
adjusted risk of death in hospital beyond that from blood
culture testing (Figure 3B-E, Additional file 1). This risk
was higher in bloodstream infections identified in the
first 24 hours of the admission and in those due to mul-
tiple microorganisms (Figure 3B vs. 3D and Figure 3C
vs. 3E). In addition, the adjusted risk of death associated
with bloodstream infections increased significantly in pa-
tients exposed to immunosuppressives, those who were
neutropenic, or both. On the first day of bloodstream in-
fection, the adjusted relative hazard of death in hospital
varied from a low of 3.8 [95% CI 3.1-4.6] (in: emergently
admitted patients; with low comorbidity; not in the ICU;
without neutropenia; not on immunosuppresives; with a
bloodstream infection from a single organism during the
hospitalization) to 24.3 [95% CI 16.6-35.4] (in: electively
admitted patients; with high comorbidity; in the ICU; with
neutropenia; on immunosuppresives; with a polymicrobial
bloodstream infection identified in the first 24 hours of
the hospitalization). As with negative blood cultures, the
increased risk of death from bloodstream infections de-
creased significantly over time (Figure 3B-3E).
The influence of bloodstream infection on the inde-
pendent risk of death in hospital varied significantly
by the microorganism isolated in the culture (Figure 4).
A B C D E
Figure 3 Adjusted influence of negative blood cultures/bloodstream infection on hospital mortality by significant effect modifiers.
These plots present the adjusted hazard ratio (vertical axes) for the association of negative blood cultures (“No BSI”) and bloodstream infection
with death in hospital in the first 2 weeks following blood culture testing (horizontal axes). Adjusted hazard ratios for negative blood cultures are
presented for all combinations of admission urgency (elective vs. emergent), patient comorbidity status (low comorbidity [Elixhauser score of 1]
vs. high comorbidity [Elixhauser score of 12]), and intensive care unit (ICU) status. Adjusted hazard ratios for bloodstream infection (calculated for
patients with low comorbidity, low comorbidity, and not in the ICU) are presented for all combinations of immunosuppressant exposure and
neutropenia. All hazard ratios adjust for: patient age; patient sex; admission service (i.e. medical or surgical) and diagnosis; severity of acute illness
as measured by the Laboratory-based Acute Physiology Score (LAPS); chronic comorbidities as measured by the Elixhauser score [20]; treatment
in the intensive care unit; performance of significant operative procedures [23]; awaiting long-term care status; [19] and exposure to
immunosuppressant medications. All adjusted hazard ratios use as a comparator a person an electively admitted person with low comorbidity not in
the ICU who has no blood culture measured.
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Bloodstream infections with Clostridial, Candida, and
other gram negative/variable bacilli had adjusted death
risks that were notably higher than the other micro-
organisms. Figure 4 also highlights the striking increased
risk of death in hospital from bloodstream infection when
patients were neutropenic and exposed to immuno-
supressives.
The study’s conclusions did not change significantly
when we repeated the analysis with the patient – rather
than the admission – as the unit of analysis (Additional
file 2). All but one of the parameter estimates in the pa-
tient model - that for polymicrobial status - remained
within the 95% confidence intervals of the hospitalization
model (Additional file 1). Changes in the influence of
polymicrobial status on mortality might be due to a
change in statistical power (i.e. a reduction in the number
of polymicrobial cases when the unit of analysis changed
to the patient) or might indicate that repeated polymicro-
bial bloodstream infections (which would be in the model
having the hospitalization – but not the patient - as the
unit of analysis) have a particularly poor outcome. In
addition, consideration of competing risks indicated little
chance of biased results in our original model with minis-
cule parameter estimates in the competing risks model for
all study covariates (Additional file 3).
Discussion
To our knowledge, this is the most extensive examin-
ation of the association between blood culture testing
and bloodstream infections on hospital mortality. We
found that blood culture testing was common and that
bloodstream infections were detected in almost 2% of
hospitalizations. Patients undergoing blood culture test-
ing were much sicker and had a notably higher risk of
death in hospital that peaked around the time of their
test. Even after adjusting for important confounders,
patients with negative blood cultures still had a signifi-
cantly increased risk of death in hospital. The risk of
death was higher still in those with bloodstream infec-
tions with the risk being highest in bloodstream infec-
tions that: were detected in the first hospital day; were
polymicrobial; occurred during a neutropenic episode or
Figure 4 Independent association of specific microorganism classes with hospital death risk. These plots present the adjusted hazard ratio
of death in hospital (horizontal axis) for patients without blood culture testing, those with negative blood cultures, and those with bloodstream
infections caused by different microorganisms (vertical axis). Estimates are provided with 95% confidence intervals and are presented for patients
without immunosuppressive or neutropenia (Plot A) and for patients with immunosuppressive or neutropenia (Plot B). In both plots, adjusted
hazard ratios are relative to people without blood culture testing. Microorganisms whose adjusted relative hazard is statistically distinct from
patients with culture negative blood cultures are indicated in red.
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while exposed to immunosuppressants; or those due to
Clostridial and Candidal organisms.
Our study has several important findings. First, we
found that the independent risk of death in hospital in-
creased significantly whenever blood cultures were or-
dered, even when those blood cultures did not grow a
microorganism. This indicates that patients undergoing
blood culture testing are sicker than others, even after
adjusting for measured covariates that distinguished
these patient groups (Table 1). Obviously, we do not be-
lieve that the actual act of measuring blood cultures in-
creases the risk of death in hospital. Instead, we suspect
that an increased risk of subsequent bad outcomes re-
gardless of the blood cultures result is due to the test in-
dicating a sicker population than is indicated by the
measured covariates. We believe that this phenomenon
is likely true for other tests (such as electrocardiogram,
portable chest radiograph, cardiac enzymes, and arterial
blood gases) that are done when patients deteriorate
acutely. This observation should be considered when ana-
lyzing the influence of abnormal test results on hospital
outcomes. Second, we found that the increased independ-
ent risk of death in hospital associated with negative blood
cultures and bloodstream infections was maximal at the
time that the blood culture was procured and decreased
significantly over time. This likely reflects the benefit of
treatments given to surviving patients. Finally, the harmful
effect of bloodstream infections was highest with particu-
lar microorganisms (notably Clostridial and Candidal)
and in immunocompromised hosts (those exposed to im-
munosuppressive agents and those with neutropenia).
These results confirm how such patients with bloodstream
infection must be treated aggressively.
Our study has several interesting comparisons with
previous analyses of bloodstream infections and hospital
mortality. The distribution of microorganisms that we
identified in our cohort was very similar to that identi-
fied in previous analyses [2,5,12,13,15]. Similar to our re-
sults, several other analyses have found particularly high
mortality rates in patients with Candidal bloodstream
infection [5,6,14-16]. To our knowledge, ours is the most
extensive analysis that included patients without blood
cultures and those with negative blood cultures; this
characteristic is necessary to precisely gauge the influ-
ence of bloodstream infection on mortality risk relative
to other patients and independent of confounders associ-
ated with the actual measurement of blood cultures.
Finally, several studies had previously found – in contrast
to our study – that mortality risk was higher in those with
nosocomial bloodstream infections [2,12,14,16]. We be-
lieve that these analyses are susceptible to time-dependent
bias [26] since patients must remain alive in hospital for a
specified period of time to be classified with nosocomial
bloodstream infection. Since patients who remain in
hospital longer tend to be sicker, such analyses could
falsely attribute mortality risk from confounders in these
patients to nosocomial bloodstream infection. Analyz-
ing bloodstream infection as a time-dependent covariate
within a survival model – as we did in this analysis –
avoids this potential bias [25].
Our study has several notable attributes. We captured
all hospitalizations, all blood cultures, and all bloodstream
infections at our hospital during the study period. Our
statistical model recognized the time-dependent nature of
blood culture testing, bloodstream infections, and their as-
sociation with death in hospital. However, several poten-
tial limitations of our study should be kept in mind. First,
although we found that bloodstream infection was associ-
ated with an increased risk of death in hospital, we have
no way of determining whether the infection actually
caused the death. Primary data review would be needed to
determine – if possible – whether or not the bloodstream
infection caused a particular patient’s death. Such analyses
are necessary to determine if and how we might intervene
to improve outcomes with hospital-associated blood-
stream infections. Second, our data did not account for
treatment of bloodstream infections. Outcomes in patients
admitted for community acquired pneumonia are im-
proved significantly in those who receive antibiotics more
quickly [27]. Berjohn et al. [11] found that patients with
pneumococcal bacteremia receiving least 1 active anti-
biotic within 4 hours of blood cultures were significantly
less likely to die in hospital (odds ratio [OR], 0.47; 95%
confidence interval [CI], 0.2-1.0). It is possible that timeli-
ness of appropriate antibiotics - and other interventions to
control infection - could have an independent influence
on death risk in all patients with bloodstream infections.
Third, we did not have access to information about poten-
tial sources or causes of bloodstream infections, such as
catheters. It is possible that mortality risk associated with
bloodstream infections may change significantly based on
the presence of foreign bodies. Fourth, the utilization of
blood cultures requires a physician’s response to clinical
data input and are not – by themselves – a pathophysio-
logical marker. Physicians will vary in their response to
various clinical data and, as such, will have different
thresholds or likelihoods for ordering blood cultures.
Therefore, the external validity of our findings to other
centres could be questioned. However, supporting the
generalizability of our findings is the large size and long
duration of the study as well as its complete capture of all
blood cultures at our large institution, all of which will en-
sure a large number of different physicians who were cap-
tured by the analysis.
Conclusions
In summary, our study found that the risk of death in
hospital is independently increased in patients with
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either negative blood cultures or bloodstream infections.
In addition, death risk associated with bloodstream in-
fections varied significantly by the patient’s immune sta-
tus and the causative microorganism.
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